Bristol-Myers Squibb Earnings: A Pharma Game Changer?

Bristol-Myers Squibbs first quarter earnings, set to be released tomorrow, have investors on edge. Despite expectations of a four point five percent revenue dip, the companys performance last quarter was impressive, with twelve point five billion dollars in revenue, a one point three percent year over year increase. The stock has been sliding, but a strong performance could boost investor confidence. Wall Street is optimistic, with most revenue estimates increased in the last thirty days. As the first big pharma name to report, BMYs performance could set the tone for the pharmaceutical sector. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0766b43e77abf9d9